about
Extracellular Vesicles in Chronic Obstructive Pulmonary DiseaseAnalysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.Pathogens in COPD exacerbations identified by comprehensive real-time PCR plus older methods.Suppression of autophagy by extracellular vesicles promotes myofibroblast differentiation in COPD pathogenesisExtracellular vesicles in lung cancer-From bench to bedside.Exosomes: toward clinical application.Metformin attenuates lung fibrosis development via NOX4 suppression.Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagyInvolvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.Extracellular Vesicles: New Players in Lung Immunity.Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.Organizing pneumonia complicated by cyst and pneumothorax formation.PRKN-regulated mitophagy and cellular senescence during COPD pathogenesisClinical Application of Mesenchymal Stem Cell-Derived Extracellular Vesicle-Based Therapeutics for Inflammatory Lung DiseasesPulmonary Artery Pseudoaneurysm Caused by Lung AbscessInvolvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis PathogenesisA miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracyInvolvement of Lamin B1 Reduction in Accelerated Cellular Senescence during Chronic Obstructive Pulmonary Disease PathogenesisInvolvement of cigarette smoke-induced epithelial cell ferroptosis in COPD pathogenesisRe-administration of pembrolizumab with prednisolone after pembrolizumab-induced nephrotic syndrome
P50
Q28078352-2617E3A9-BB0D-460C-8A5C-EE3184E100B3Q35906474-7924D174-0DBD-4C83-9551-A2EC6A992F29Q36110905-A3CE184A-C6F7-4A41-9F4A-466D4EADFCE1Q36275264-36B153F7-B1EC-4CAC-AC39-72700DD77640Q38924869-2771E37B-F325-4A48-8C5C-4128FF3F88A0Q39162280-C8C605C4-D02B-412D-944F-45C93BD9F22DQ40984750-BA504784-1727-4340-A79E-7F7A76F12509Q42224355-91315F4B-AC45-49FD-BE73-BDEBAC70BE67Q46535436-E4AD3640-791C-426E-9989-063912122754Q47426170-E6DE7049-56B7-40BA-B8EF-6342720F8981Q47863231-A8D36B1A-8503-4C6D-AD5E-B28ED93035E9Q53132734-0C0DD04A-C9E3-4D79-A3B8-BC76E6040468Q57021009-C1636DE6-2D7F-4CBE-B307-2A23D8225856Q57467367-678F9D30-8675-4890-8599-FC500CD7D264Q89514993-57A5FF86-E7F8-4DD2-A6C0-101CA14E5E44Q90167506-57EC4225-C130-4B3E-AA18-0F73C1BF5AF8Q90471944-43190107-CC09-4E33-A388-764E8DAB9A41Q91258338-6B22BAE9-9D99-4234-96C5-023C8AFB07AFQ91968046-BAE9D5C4-B0F9-460E-8DFC-A9EF2B65989DQ92556915-BCAFAB8E-6B23-4ED0-939E-6240B75C6673
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Tsukasa Kadota
@en
Tsukasa Kadota
@nl
type
label
Tsukasa Kadota
@en
Tsukasa Kadota
@nl
prefLabel
Tsukasa Kadota
@en
Tsukasa Kadota
@nl
P108
P31
P496
0000-0002-9533-7241